Arrowhead Pharmaceuticals(ARWR)
$47.15-2.21 (-4.48%)
ARWR
Arrowhead Pharmaceuticals stock drug pipeline
$47.15
At close:-2.21 (-4.48%)
Want to see ARWR full AI Analyst Report?
Arrowhead Pharmaceuticals (ARWR) Drug Pipeline
1,735 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arrowhead Pharmaceuticals, Inc. (ARWR) have in its pipeline
Arrowhead Pharmaceuticals ARWR is currently developing the following drugs: Aro-033, Zodasiran, Aro-Ang3, Aro-Rage, Aro-Dimerpa, Aro-Mapt-Sc, Zodasiran Injection, Aro-Alk7, Plozasiran, Plozasiran Injection, Tirzepatide, Aro-Inhbe, Aro-Atxn2 Injection, Aro-Cfb, Aro-Dm1 For Injection, Aro-Dux4 For Injection, Vsa001 Injection, Aro-Mmp7 Inhalation Solution, Aro-Apoc3, Aro-Muc5ac, Aro-Ang 3 Injection, Aro-C3, Aro-Ang3, Aro-Enac, Sterile Normal Saline, Aro-Hsd Injection, Aro-Hif2, Fazisiran Injection, Aro-Aat, Sterile Normal Saline, Aro-Hbv, Jnj-56136379. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

